查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475014

全球製藥片劑包衣市場評估：依類型、依聚合物類型、依功能、依最終用戶、依地區、機會、預測（2017-2031）

Pharma Tablet Coatings Market Assessment, By Type, By Polymer Type, By Functionality, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 238 Pages | 商品交期: 3-5個工作天內

價格

全球藥品錠劑包衣市場規模預計將從 2023 年的 10.1 億美元增至 2031 年的 16.2 億美元，預計 2024-2031 年複合年增長率為 6.1%。 市場成長受到製藥業擴張和研發活動增加的支持。

製藥業的快速成長正在推動全球藥品片劑包衣市場規模的擴大。 這種增長是由於世界不同地區各種疾病和病症的日益普及以及人口的快速增長。 例如，投資印度公司預測，到2030年，該國的製藥業將達到1,300億美元。 此外，對藥品生產品質的日益關注和仿製藥的日益採用為市場提供了利潤豐厚的成長機會，並增加了對藥片包衣的需求。 對各種輔料和藥品的更嚴格監管進一步推動了市場擴張。

市場主要參與者增加投資來製造設備，幫助以具成本效益的方式及時交付可行的藥片包衣，進一步推動市場成長。 此外，生物相似藥因其成本效益而日益受歡迎，增加了各種治療的可及性並改善了患者的生活質量，也推動了市場的擴張。 例如，安進生物相似藥公司的《2022年生物相似藥趨勢報告》估計，過去三年推出的生物相似藥的平均治療領域佔有率為75%。 生物相似藥模仿參考生物製品的活性成分，並經過廣泛的分析，以確認與參考生物製品存在相似的特性。 因此，生物相似藥行業顯示出顯著增長，促使對藥物片劑包衣的需求增加，對市場擴張產生積極影響。

仿製藥擴散帶動市場需求

仿製藥的日益普及可歸因於其成本效益以及人們對這些藥物必須遵守的嚴格監管標準的認識不斷增強。 要獲得 FDA 的批准，仿製藥必須與品牌藥具有生物等效性。 這確保了兩種藥物的化學成分相同，儘管仿製藥製造商可以將原廠藥的活性成分改變 20%。 FDA 的容忍度高達 20%，但變化通常小於 4%。 消費者對仿製藥須遵守的嚴格監管標準的認識不斷提高，從而增強了對仿製藥的信任。 例如，無障礙藥物協會估計，美國大約 90% 的處方都是仿製藥。 這增加了對藥片包衣的需求並支持市場成長。

藥片包衣技術的進步提供了利潤豐厚的成長機會

引入新的製程分析技術 (PAT) 工具來收集數據並即時監控薄膜包衣操作是全球藥物片劑包衣市場的新興趨勢。 各種 PAT 工具包括多種技術，例如用於監測薄膜塗覆操作的顯微鏡、光譜學和成像技術。 近年來，各種先進技術的成功開發提高了塗裝作業的可擴展性。 例如，對拉曼光譜技術進行了各種改進，使其更易於使用、具有更緊湊的外形並提高了校準穩定性。 同樣，羅格斯大學的研究小組全面評估了先進的多點近紅外線空間分辨光譜 (SRS) 探頭。 這些探頭可實現快速、準確的測量。 該技術具有高效率和高精度，每小時可測試約 20 萬片藥片。 預計此類發展和進步將在預測期內為市場提供利潤豐厚的成長機會。

本報告研究和分析了全球藥品片劑包衣市場，提供市場規模和預測、市場動態、主要參與者的現狀和前景等。

目錄

第一章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第 4 章顧客回饋

  • 市場認知度與產品訊息
  • 品牌知名度與忠誠度
  • 購買決策時考慮的因素
  • 購買頻率
  • 購買介質

第五章全球藥片包衣市場展望（2017-2031）

  • 市場規模與預測
    • 金額
    • 數量
  • 依類型
    • 糖衣
    • 薄膜塗層
    • 腸溶衣
    • 明膠塗層
    • 其他
  • 依聚合物型
    • 纖維素
    • 乙烯基
    • 亞克力
    • 其他
  • 功能性別
    • 延遲發佈
    • 緩慢釋放
  • 依最終用戶
    • 醫藥
    • 營養補充品
  • 依地區
    • 北美
    • 南美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 市佔率：依公司劃分（2023 年）

第 6 章全球製藥錠劑包衣市場展望：依地區劃分（2017-2031 年）

  • 北美
    • 市場規模與預測
    • 依類型
    • 依聚合物型
    • 功能性別
    • 依最終用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 南美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第七章供給面分析

  • 生產能力：依公司劃分
  • 生產：依公司劃分
  • 營運效率：依公司劃分
  • 主要工廠地點（最多 25 個地點）

第 8 章市場地圖（2023 年）

  • 依類型
  • 依聚合物型
  • 功能性別
  • 依最終用戶
  • 依地區

第九章宏觀環境與產業結構

  • 需求與供給分析
  • 進出口分析
  • 供應鏈分析
  • PESTEL 分析
  • 波特五力分析

第 10 章市場動態

  • 生長促進因素
  • 抑製成長的因素（問題、限制因素）

第十一章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析（2023 年）
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家市場公司）
  • 專利分析（如果適用）

第十二章價格分析

第 13 章案例研究

第14章主要公司展望

  • NEHA LIFE SCIENCES PVT. LTD.
  • UPM Pharmaceuticals, Inc.
  • Evonik Industries
  • BASF Pharma
  • Colorcon
  • EasyCoat
  • METTLER TOLEDO
  • Lonza
  • Qualicaps
  • SPI Pharma

第 15 章策略建議

第16章關於我們公司，免責聲明

Product Code: MX11281

Global pharma tablet coatings market is projected to witness a CAGR of 6.1% during the forecast period 2024-2031, growing from USD 1.01 billion in 2023 to USD 1.62 billion in 2031F. The growth of the market is supported by the expansion in the pharmaceutical sector and increasing research and development activities.

The rapid growth of the pharmaceutical sector is boosting the global pharma tablet coatings market size. The growth can be attributed to the increasing prevalence of various diseases and disorders and exponential rise in population in various regions across the globe. For instance, Invest India estimated that the pharmaceutical industry in the country is expected to reach USD 130 billion by 2030. Moreover, the increasing emphasis on the quality of pharmaceutical products manufacturing and rising adoption of generic drugs provide lucrative growth opportunities to the market, boosting the requirement for pharma tablet coatings. The increase in stringency by regulatory bodies regarding different excipients and drugs further bolstered the market expansion.

The rising investments by key players in the market to produce equipment that supports the delivery of viable pharma tablet coatings cost-efficient and timely are further propelling the global pharma tablet coatings market growth. Additionally, the rising popularity of biosimilars owing to their cost-effective nature, which increases the accessibility to various treatments and improves the quality of life of the patients, is supporting the expansion of the market for tablet coatings. For instance, 2022 Biosimilar Trends Report by Amgen Biosimilars estimates that for the biosimilars launched in the past three years, in the therapeutic areas, average share was 75%. Biosimilars mimic the active ingredient in the reference biologic and undergo extensive analysis to confirm the presence of similar characteristics to that of the reference biologics. Thus, the biosimilars sector is witnessing significant growth, which in turn is boosting the requirement for pharma tablet coatings and positively influencing the expansion of the market.

Increasing Adoption of Generics Boost Global Pharma Tablet Coatings Market Demand

The growing popularity of generics can be attributed to their cost-effective nature and the rising awareness of strict regulatory standards these drugs must follow. To receive the stamp of approval from the FDA, the generic drugs must be bioequivalent to their brand-name counterpart. It ensures that two drugs are chemically the same, though the makers of the generic medication are allowed a variation of twenty percent in the active ingredient from the original formula. Even though the wiggle room allowed by the FDA is up to 20%, variations of less than 4% are usually observed. Due to the increasing awareness among the general population about such strict regulatory standards followed by generic medications has boosted confidence in such drugs. For instance, the Association for Accessible Medicines estimates that approximately 90% of the prescriptions dispensed in the United States are of generics. Thus boosting the demand for pharma-coating tablets and supporting the market's growth.

Technological Advancements in Pharma Tablet Coatings Provide Lucrative Growth Opportunities

Introducing new process analytical technology (PAT) tools for data acquisition and real-time monitoring for filming coating operations is an emerging global pharma tablet coatings market trend. Various PAT tools include a wide range of techniques, such as microscopic techniques, spectroscopic techniques, and imaging techniques, to monitor the film coating operations. Recently, the successful development of various advanced technologies has aided in enhancing the scalability of the coating operations. For instance, the Raman spectroscopy technology underwent various improvements to make it more user-friendly, achieving a more compact form factor, and enhance the calibration stability. Similarly, a research group at Rutgers University comprehensively evaluated advanced multi-point NIR spatially resolved spectroscopy (SRS) probes. These probes provide rapid and precise measurements. The high efficiency and precision offered by this technology has allowed the inspection of approximately 200,000 tablets per hour. Such developments and advancements will provide lucrative growth opportunities to the market over the forecast period.

North America Accounts for a Significant Share of the Market

The growth of North America pharma tablet coatings market can be attributed to the rapid expansion of pharmaceutical sector in the region, strong presence of various leading market players, and increasing prevalence of several diseases and disorders. The rising investments by the market players based in the region towards the development of novel products and technologies are further aiding the growth of the market in North America.

For instance, in May 2023, Colorcon, headquartered in Pennsylvania, United States, introduced titanium dioxide-free film coating designed to mitigate the challenges associated with moisture-sensitive actives. Colorcon launched an Opadry film coating system that meets the moisture management requirements of pharmaceutical tablets without utilizing titanium dioxide. Through their portfolio of Opadry complete film coating systems, the company provides scope for reducing time-to-market and complexity by providing high-quality products to their customers. They are focused on carefully selecting ingredients that meet the local pharmaceutical regulatory requirements. Such regional developments will provide lucrative growth opportunities for the North American market.

Sustained Release Holds Significant Share of the Market

The growth of the segment can be attributed to the increasing prevalence of various diseases and disorders that require sustained and controlled release of drugs, including hypertension, diabetes, and asthma. For instance, the International Diabetes Federation estimated that, in 2021, approximately 10.5% of the adult population, i.e., individuals between the age of 20-79 years had diabetes. Also, by 2045 the number of cases of diabetes will witness an increase of 46% and 1 in 8 adults, about 783 million individuals will be living with diabetes. The increase in prevalence of diabetes will boost the requirement for sustained release pharma tablet costings, augmenting the market's growth.

Additionally, the utilization of sustained-release tablets offers various advantages, including slow drug release in the bloodstream, which allows for maintaining a constant level of medication in the bloodstream and removes the likelihood of burst drug release. Thus, it boosts demand and propels the market expansion.

Pharmaceutical Sector Accounts for Significant Market Share

The expansion of the pharmaceutical sector can be attributed to the exponential growth of the geriatric population, the increase in the prevalence of several diseases, and rising healthcare expenditure in various countries across the globe. Due to the growth, the requirement for pharma tablet coatings is increasing, augmenting the market demand. Additionally, the demand for tablet coatings by the pharmaceutical sector is augmenting as the prevalence of diseases that require tablet formulations as the primary form of treatment rises.

For instance, the rise in the number of cases of arthritis is boosting the demand for global pharma tablet coatings. According to the estimates of the Centers for Disease Control and Prevention, an estimated 53.2 million adults in the United States, approximately 21.2% of the population, have been diagnosed by a doctor to have some form of arthritis in 2023. The increase in the number of cases of arthritis is providing lucrative growth opportunities to the market as various corticosteroid medications are consumed as pills for slowing the joint damage and reducing pain and inflammation. Thus, boosting the requirement for pharma tablet coatings and supporting the expansion of the market.

Future Market Scenario (2024 - 2031F)

According to global pharma tablet coatings market analysis, the increasing emphasis on nanocoating technology will support the expansion of the market in the coming years. The growing utilization of nanotechnology will aid in enhancing the capabilities of the excipients. Nanocoating will aid in improving drug release profiles by enhancing the bioavailability of active pharmaceutical ingredient and controlling the release rate. Furthermore, the utilization of nanocoating technology will support the incorporation of different functional materials including antimicrobial agents, flavoring agents, antioxidants, and polymers, onto the surface of the tablet. The increasing utilization of nanocoating technology will provide various benefits and support the expansion of the market for pharma tablet coatings over the forecast period.

Key Players Landscape and Outlook

The increasing investments by the leading pharma tablet coatings market players towards the development of new coating manufacturing facilities will support the global pharma tablet coatings market growth. For instance, Colorcon is investing in the development of a new manufacturing facility in Johor State, Malaysia, through their subsidiary, Colorcon Malaysia. The facility will be producing advanced and high-quality film-coating products to cater to the requirements of nutraceutical and pharmaceutical manufacturers across the region of the Southeast Asia, comprising of New Zealand and Australia. With an investment of approximately USD 50 million, the strategic approach of Colorcon to be located closer to their customers will boost the ability of the company to cater to the expected growth in the region. Thus, increase in such investments over the forecast period will provide lucrative growth opportunities for the market.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Market Awareness and Product Information
  • 4.2.Brand Awareness and Loyalty
  • 4.3.Factors Considered in Purchase Decision
    • 4.3.1.Brand Name
    • 4.3.2.Quality
    • 4.3.3.Quantity
    • 4.3.4.Price
    • 4.3.5.Product Specification
    • 4.3.6.Form Specification
    • 4.3.7.Shelf Life
    • 4.3.8.Availability of Product
  • 4.4.Frequency of Purchase
  • 4.5.Medium of Purchase

5.Global Pharma Tablet Coatings Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
    • 5.1.2.By Volume
  • 5.2.By Type
    • 5.2.1.Sugar Coated
    • 5.2.2.Film Coated
    • 5.2.3.Enteric Coated
    • 5.2.4.Gelatin Coated
    • 5.2.5.Others
  • 5.3.By Polymer Type
    • 5.3.1.Cellulosic
    • 5.3.2.Vinyl
    • 5.3.3.Acrylic
    • 5.3.4.Others
  • 5.4.By Functionality
    • 5.4.1.Delayed-Release
    • 5.4.2.Sustained-Release
  • 5.5.By End-user
    • 5.5.1.Pharmaceutical
    • 5.5.2.Nutraceutical
  • 5.6.By Region
    • 5.6.1.North America
    • 5.6.2.South America
    • 5.6.3.Europe
    • 5.6.4.Asia-Pacific
    • 5.6.5.Middle East and Africa
  • 5.7.By Company Market Share (%), 2023

6.Global Pharma Tablet Coatings Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
      • 6.1.1.2.By Volume
    • 6.1.2.By Type
      • 6.1.2.1.Sugar Coated
      • 6.1.2.2.Film Coated
      • 6.1.2.3.Enteric Coated
      • 6.1.2.4.Gelatin Coated
      • 6.1.2.5.Others
    • 6.1.3.By Polymer Type
      • 6.1.3.1.Cellulosic
      • 6.1.3.2.Vinyl
      • 6.1.3.3.Acrylic
      • 6.1.3.4.Others
    • 6.1.4.By Functionality
      • 6.1.4.1.Delayed-Release
      • 6.1.4.2.Sustained-Release
    • 6.1.5.By End-user
      • 6.1.5.1.Pharmaceutical
      • 6.1.5.2.Nutraceutical
    • 6.1.6.United States*
      • 6.1.6.1.Market Size & Forecast
        • 6.1.6.1.1.By Value
        • 6.1.6.1.2.By Volume
      • 6.1.6.2.By Type
        • 6.1.6.2.1.Sugar Coated
        • 6.1.6.2.2.Film Coated
        • 6.1.6.2.3.Enteric Coated
        • 6.1.6.2.4.Gelatin Coated
        • 6.1.6.2.5.Others
      • 6.1.6.3.By Polymer Type
        • 6.1.6.3.1.Cellulosic
        • 6.1.6.3.2.Vinyl
        • 6.1.6.3.3.Acrylic
        • 6.1.6.3.4.Others
      • 6.1.6.4.By Functionality
        • 6.1.6.4.1.Delayed-Release
        • 6.1.6.4.2.Sustained-Release
      • 6.1.6.5.By End-user
        • 6.1.6.5.1.Pharmaceutical
        • 6.1.6.5.2.Nutraceutical
    • 6.1.7.Canada
    • 6.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East and Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Supply Side Analysis

  • 7.1.Capacity, By Company
  • 7.2.Production, By Company
  • 7.3.Operating Efficiency, By Company
  • 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

  • 8.1.By Type
  • 8.2.By Polymer Type
  • 8.3.By Functionality
  • 8.4.By End-user
  • 8.5.By Region

9.Macro Environment and Industry Structure

  • 9.1.Supply Demand Analysis
  • 9.2.Import Export Analysis
  • 9.3.Supply Chain Analysis
  • 9.4.PESTEL Analysis
    • 9.4.1.Political Factors
    • 9.4.2.Economic System
    • 9.4.3.Social Implications
    • 9.4.4.Technological Advancements
    • 9.4.5.Environmental Impacts
    • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 9.5.Porter's Five Forces Analysis
    • 9.5.1.Supplier Power
    • 9.5.2.Buyer Power
    • 9.5.3.Substitution Threat
    • 9.5.4.Threat from New Entrant
    • 9.5.5.Competitive Rivalry

10.Market Dynamics

  • 10.1.Growth Drivers
  • 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

  • 11.1.Competition Matrix of Top Five Market Leaders
  • 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4.SWOT Analysis (For Five Market Players)
  • 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

  • 14.1.NEHA LIFE SCIENCES PVT. LTD.
    • 14.1.1.Company Details
    • 14.1.2.Key Management Personnel
    • 14.1.3.Products & Services
    • 14.1.4.Financials (As reported)
    • 14.1.5.Key Market Focus & Geographical Presence
    • 14.1.6.Recent Developments
  • 14.2.UPM Pharmaceuticals, Inc.
  • 14.3.Evonik Industries
  • 14.4.BASF Pharma
  • 14.5.Colorcon
  • 14.6.EasyCoat
  • 14.7.METTLER TOLEDO
  • 14.8.Lonza
  • 14.9.Qualicaps
  • 14.10.SPI Pharma

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 3.Global Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 4.Global Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 5.Global Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 6.Global Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Pharma Tablet Coatings Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 9.North America Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 10.North America Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 11.North America Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 12.North America Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 13.North America Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.United States Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 17.United States Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 18.United States Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 19.United States Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 20.United States Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 22.Canada Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 23.Canada Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 24.Canada Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 25.Canada Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 26.Canada Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 28.Mexico Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 29.Mexico Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 30.Mexico Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 31.Mexico Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 32.Mexico Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 34.Europe Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 35.Europe Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 36.Europe Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 37.Europe Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 38.Europe Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.Germany Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 42.Germany Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 43.Germany Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 44.Germany Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 45.Germany Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.France Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 48.France Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 49.France Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 50.France Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 51.France Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Italy Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 54.Italy Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 55.Italy Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 56.Italy Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 57.Italy Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 59.United Kingdom Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 60.United Kingdom Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 61.United Kingdom Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 62.United Kingdom Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 63.United Kingdom Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Russia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 66.Russia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 67.Russia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 68.Russia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 69.Russia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 71.Netherlands Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 72.Netherlands Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 73.Netherlands Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 74.Netherlands Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 75.Netherlands Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 77.Spain Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 78.Spain Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 79.Spain Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 80.Spain Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 81.Spain Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.Turkey Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 84.Turkey Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 85.Turkey Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 86.Turkey Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 87.Turkey Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Poland Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 90.Poland Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 91.Poland Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 92.Poland Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 93.Poland Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.South America Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 96.South America Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 97.South America Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 98.South America Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 99.South America Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.Brazil Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 103.Brazil Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 104.Brazil Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 105.Brazil Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 106.Brazil Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 108.Argentina Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 109.Argentina Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 110.Argentina Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 111.Argentina Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 112.Argentina Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 114.Asia-Pacific Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 115.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 116.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 117.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 118.Asia-Pacific Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
  • Figure 120.India Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 121.India Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 122.India Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 123.India Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 124.India Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 125.India Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.China Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 128.China Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 129.China Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 130.China Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 131.China Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 133.Japan Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 134.Japan Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 135.Japan Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 136.Japan Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 137.Japan Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 139.Australia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 140.Australia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 141.Australia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 142.Australia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 143.Australia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 145.Vietnam Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 146.Vietnam Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 147.Vietnam Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 148.Vietnam Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 149.Vietnam Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 151.South Korea Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 152.South Korea Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 153.South Korea Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 154.South Korea Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 155.South Korea Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 157.Indonesia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 158.Indonesia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 159.Indonesia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 160.Indonesia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 161.Indonesia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 163.Philippines Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 164.Philippines Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 165.Philippines Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 166.Philippines Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 167.Philippines Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 169.Middle East & Africa Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 170.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 171.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 172.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 173.Middle East & Africa Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 176.Saudi Arabia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 177.Saudi Arabia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 178.Saudi Arabia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 179.Saudi Arabia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 180.Saudi Arabia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.UAE Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 183.UAE Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 184.UAE Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 185.UAE Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 186.UAE Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
  • Figure 188.South Africa Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
  • Figure 189.South Africa Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
  • Figure 190.South Africa Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
  • Figure 191.South Africa Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
  • Figure 192.South Africa Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194.By Polymer Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195.By Functionality Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023